LMR Partners’s Lunai Bioworks LNAI Stock Holding History

LMR Partners’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-210	Closed	-$138K	–	1436
2022 Q1	$138K	Buy	210 +42	+25%	+$22.4K	﹤0.01%	1168
2021 Q4	$98K	Buy	+168	New	+$122K	﹤0.01%	1112

Other funds holding LNAI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LMR Partners's LNAI Position: Q2 2022 in Review

LMR Partners sold out of Lunai Bioworks (LNAI) in Q2 2022, closing a stake of 210 shares — an estimated $138K sold.

LMR Partners first reported a position in LNAI in Q4 2021 and held it in 2 quarters. The position peaked at $138K in Q1 2022. 51 funds tracked by Wall St. Rank hold LNAI as of Q2 2022.

LMR Partners reported no remaining Lunai Bioworks position as of Q2 2022 after selling out during the quarter.
LMR Partners sold 210 Lunai Bioworks shares in Q2 2022, an estimated $138K.
LMR Partners first reported a position in Lunai Bioworks in Q4 2021 and held it in 2 quarters.
LMR Partners's Lunai Bioworks position peaked at $138K in Q1 2022.
51 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2022.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.